Page 71 - Read Online

Page 18 of 23 Poznyak et al. Microbiome Res Rep. 2026;5:3

68. Gargari G, Mantegazza G, Cremon C, et al. Collinsella aerofaciens as a predictive marker of response to probiotic treatment in
non-constipated irritable bowel syndrome. Gut Microbes. 2024;16:2298246. DOI PubMed PMC
69. Chen J, Wright K, Davis JM, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med.
2016;8:43. DOI PubMed PMC
70. Korzeniowska A, Bryl E. Infectious and commensal bacteria in rheumatoid arthritis-role in the outset and progression of the disease. Int
J Mol Sci. 2024;25:3386. DOI PubMed PMC
71. Romano S, Wirbel J, Ansorge R, et al. Machine learning-based meta-analysis reveals gut microbiome alterations associated with
Parkinson’s disease. Nat Commun. 2025;16:4227. DOI PubMed PMC
72. Vandeputte D, Kathagen G, D’hoe K, et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature.
2017;551:507-11. DOI
73. Knight R, Vrbanac A, Taylor BC, et al. Best practices for analysing microbiomes. Nat Rev Microbiol. 2018;16:410-22. DOI
74. Gloor GB, Macklaim JM, Pawlowsky-Glahn V, Egozcue JJ. Microbiome Datasets are compositional: and this is not optional. Front
Microbiol. 2017;8:2224. DOI PubMed PMC
75. Juárez-Chairez MF, Cid-Gallegos MS, Jiménez-Martínez C, Prieto-Contreras LF, Bollain-Y-Goytia de-la-Rosa JJ. The role of
microbiota on rheumatoid arthritis onset. Int J Rheum Dis. 2024;27:e15122. DOI PubMed
76. Wagner S, Weber M, Paul LS, et al. Absolute abundance calculation enhances the significance of microbiome data in antibiotic
treatment studies. Front Microbiol. 2025;16:1481197. DOI PubMed PMC
77. Guo C, Che X, Briese T, et al. Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network
disturbances and fatigue symptoms in ME/CFS. Cell Host Microbe. 2023;31:288-304.e8. DOI PubMed PMC
78. Liu Z, Wu Y, Luo Y, et al. Self-balance of intestinal flora in spouses of patients with rheumatoid arthritis. Front Med (Lausanne).
2020;7:538. DOI PubMed PMC
79. Sadeghpour Heravi, F. Gut microbiota and autoimmune diseases: mechanisms, treatment, challenges, and future recommendations. Curr
Clin Micro Rpt. 2024;11:18-33. DOI
80. Jeong JJ, Park HJ, Cha MG, et al. The lactobacillus as a probiotic: focusing on liver diseases. Microorganisms. 2022;10:288. DOI
PubMed PMC
81. Chen JF, Ou-Yang MC, Hsia KC, et al. A three-arm, randomized, double-blind, placebo-controlled study to evaluate the safety of
Lactobacillus salivarius AP-32 and Bifidobacterium animalis CP-9 used individually in healthy infants. Nutrients. 2023;15:3426. DOI
PubMed PMC
82. Yang Y, Hong Q, Zhang X, Liu Z. Rheumatoid arthritis and the intestinal microbiome: probiotics as a potential therapy. Front Immunol.
2024;15:1331486. DOI PubMed PMC
83. Esvaran M, Conway PL. Lactobacillus fermentum PC1 has the capacity to attenuate joint inflammation in collagen-induced arthritis in
DBA/1 mice. Nutrients. 2019;11:785. DOI PubMed PMC
84. Paul AK, Paul A, Jahan R, et al. Probiotics and amelioration of rheumatoid arthritis: significant roles of Lactobacillus casei and
Lactobacillus acidophilus. Microorganisms. 2021;9:1070. DOI PubMed PMC
85. Fan Z, Ross RP, Stanton C, et al. Lactobacillus casei CCFM1074 alleviates collagen-induced arthritis in rats via balancing Treg/Th17
and modulating the metabolites and gut microbiota. Front Immunol. 2021;12:680073. DOI PubMed PMC
86. Ferro M, Charneca S, Dourado E, Guerreiro CS, Fonseca JE. Probiotic supplementation for rheumatoid arthritis: a promising adjuvant
therapy in the gut microbiome era. Front Pharmacol. 2021;12:711788. DOI PubMed PMC
87. Bungau SG, Behl T, Singh A, et al. Targeting probiotics in rheumatoid arthritis. Nutrients. 2021;13:3376. DOI PubMed PMC
88. Rahman SO, Bariguian F, Mobasheri A. The potential role of probiotics in the management of osteoarthritis pain: current status and
future prospects. Curr Rheumatol Rep. 2023;25:307-26. DOI PubMed PMC
89. Thomas S, Izard J, Walsh E, et al. The host microbiome regulates and maintains human health: a primer and perspective for
non-microbiologists. Cancer Res. 2017;77:1783-812. DOI
90. Godha Y, Kumar S, Wanjari A. Role of gut microbiota in the development and management of rheumatoid arthritis: a narrative review.
Cureus. 2023;15:e49458. DOI PubMed PMC
91. Orekhov AN, Summerhill VI, Khotina VA, Popov MA, Uzokov JK, Sukhorukov VN. Role of mitochondria in the chronification of
inflammation: focus on dysfunctional mitophagy and mitochondrial DNA mutations. Gene Expr. 2023;22:329-44. DOI
92. Lukas C, Mary J, Debandt M, et al. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid
arthritis: data from the ESPOIR cohort. Arthritis Res Ther. 2019;21:243. DOI PubMed PMC
93. Heydari-Kamjani M, Demory Beckler M, Kesselman MM. Reconsidering the use of minocycline in the preliminary treatment regime of
rheumatoid arthritis. Cureus. 2019;11:e5351. DOI PubMed PMC